T1	HMM 11 73	Overall Survival After Stereotactic Ablative Radiation Therapy
T2	HMM 657 694	patient, treatment, and tumor factors
T3	HMM 1111 1261	RPA identified 2 distinct risk classes based on tumor diameter, age, World Health Organization performance status (PS) and Charlson comorbidity index.
T4	HMM 1677 1703	Amsterdam prognostic model
T5	HMM 1944 1959	RPA performance
